アルツハイマー病患者の認知機能と適応に対する音楽療法の効果:ランダム化制御試験試験
Büşra Kayaaslan1, Neslihan Lök2
1Department of Nursing, Selcuk University Health Sciences Institute, Konya, Turkey.
Psychology, health & medicine
|August 26, 2025
まとめ
音楽療法は 認知機能と 介護施設の住人の適応を 大きく改善しました この非薬学的介入は精神状態を改善し,高齢者の困難を軽減しました.
科学分野:
- ゲロントロジー
- 精神科
- 音楽 療法
背景:
- 認知機能の低下や適応障害は 介護施設に暮らす高齢者の多くに見られます
- 非薬学的介入は,この集団の生活の質と幸福度を向上させることを目指しています.
研究 の 目的:
- 介護施設での高齢者の認知機能と適応レベルに対する音楽療法の影響を調査する.
- 医療における非薬学的な介入として音楽療法を評価する.
主な方法:
- 試験前後の設計によるランダム化制御試験が行われました.
- 30人の高齢者は介入 (音楽療法) と対照群に分けられました.
- 認知機能は標準化されたミニメンタルステート試験 (SMMSE) を用いて,適応能力は高齢者の適応障害評価スケール (ASADE) を用いて評価された.
主要な成果:
- 音楽療法は認知機能の有意な改善 (p < 0. 001,大きな効果サイズ) と適応困難の合計スコアの低下 (p < 0. 001,大きな効果サイズ) を示した.
- 役割,自己実現,相互の愛着,自己認識,生理学的状態を含むASADEサブスケールで改善が認められた.
- 介入グループは,SMMSEとASADEのスコアにおいて,対照群と比較して,介入後の有意な差異を示した (p < 0. 05).
結論:
- 音楽療法は 高齢者の認知機能と適応力を高める 有効な非薬物療法です
- 研究では,音楽療法が介護施設の老人ケアに組み込まれることを推奨しています.
関連する概念動画
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
01:23Role of Neurotransmitters in Memory
971
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
971
01:30Cognitive Development During Adulthood
267
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
267